• SENSEX
    NIFTY 50
Healthcare

Chinese firm says coronavirus vaccine candidate shows promise in human test

Updated : June 29, 2020 06:28 AM IST

The experimental shot, developed by a Beijing-based unit of CNBG, has induced high-level antibodies in all the inoculated participants in a Phase 1/2 clinical trial involving 1,120 healthy people, according to preliminary data of the trial.
A vaccine has to prove its effectiveness in "Phase 3" human test where thousands of participants are recruited in order to be cleared for sale.
CNBG said on Tuesday it will run a Phase 3 for its vaccine candidate in the United Arab Emirates, without specifying which shot will be tested.
Chinese firm says coronavirus vaccine candidate shows promise in human test

You May Also Like

Live TV
Advertisement